A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer

Clinical trial NCT01799278 · COMPLETED

Trial details

NCT number: NCT01799278
Sponsor: Weill Medical College of Cornell University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Prostate Cancer Neuroendocrine Prostate Cancer Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers

Start date: 2013-02-01
Primary completion: 2016-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.